New childhood leukaemia identified by gene chip technologyBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7326.1388c (Published 15 December 2001) Cite this as: BMJ 2001;323:1388
- Deborah Josefson
- San Francisco
Infants and children diagnosed with chemotherapy resistant acute lymphoblastic leukaemia, the most common childhood malignancy, may in fact have a different type of leukaemia altogether, a new study has shown.
Researchers at Harvard University's Dana Farber Cancer Institute in Boston, Massachusetts, have used gene chip technology to distinguish “mixed lineage” leukaemias from the acute form.
The study, to be published in the journal Nature Genetics in January 2002 but already available online (at genetics.nature.com), not only …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial